Response to oral supplementation in copper deficiency myeloneuropathy
Document Type
Article
Abstract
Neurological manifestations due to copper deficiency include ataxic myeloneuropathy that resembles subacute combined degeneration due to B12 deficiency. We report our experience in the treatment of 10 patients with copper deficiency myeloneuropathy and conclude that copper supplementation leads to stabilization rather than improvement in the neurological deficits. © 2008 by Lippincott Williams & Wilkins.
Publication Date
9-1-2008
Publication Title
Journal of Clinical Neuromuscular Disease
ISSN
15220443
E-ISSN
15371611
Volume
10
Issue
1
First Page
1
Last Page
3
PubMed ID
18772693
Digital Object Identifier (DOI)
10.1097/CND.0b013e3181828cf7
Recommended Citation
Kelkar, Praful; Chang, Shereen; and Muley, Suraj A., "Response to oral supplementation in copper deficiency myeloneuropathy" (2008). Neurology. 498.
https://scholar.barrowneuro.org/neurology/498
COinS